Already have an account?


Login with an existing Projects In Knowledge account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



Education Initiative in Cardiology

  • Cardiology Care Considerations — Special Considerations in Cardiology: The Era of Covid-19 – Webcast
  • Early in the Covid-19 pandemic clinicians recognized that this was not simply another flu-like condition but rather an aggressive virus that attacked multiple organ systems. In this exclusive Special Considerations video interview Robert O. Bonow, MD, MS, professor of cardiology at Northwestern University’s ... more >>
  • Stroke Prevention — Management of Coexistent Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Intervention – @Point of Care Chapter
  • Patients with both nonvalvular atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention represent a challenging subgroup of patients. The goal of treatment for these patients is to minimize the risk of stroke or systemic embolism while not increasing the risk of bleeding. Join ... more >>
  • Cardiology Care Considerations — Switching a Patient From Warfarin Therapy to a Direct Oral Anticoagulant (DOAC) – @Point of Care Chapter
  • Managing cardiac patients via telemedicine—as was often required during the Covid-19 pandemic—has many challenges. In this activity, Dr. Sanjaya Gupta discusses treatment of a patient with atrial fibrillation who wishes to switch anticoagulation regimens from warfarin to another oral anticoagulant, due to ... more >>
  • Stroke Prevention — Case Study: Primary Thromboprophylaxis for a High-Risk Outpatient With Cancer – @Point of Care Chapter
  • The incidence of venous thromboembolism (VTE) in patients with cancer is high and based on a number of factors. Risk assessment models utilize these factors to stratify patients into risk groups. Clinical judgement and experience should also aid in determining the VTE risk in an ambulatory patient with cancer ... more >>
    A. Spyropoulos, MD, FACP, FCCP, FRCPC
  • Cardiology Care Considerations — Special Considerations in Cardiology Post Covid-19: What We Know Now – Webcast
  • In year 2 of the Covid-19 Pandemic there is now a regular flow of findings about the nature of the virus, the efficacy of treatments and the protection offered by vaccines. But still unknown are ways to protect organ systems—including the cardiovascular system—from long term sequelae. In this exclusive ... more >>
  • Stroke Prevention — Antithrombotic Therapy in the Obese and Morbidly Obese – @Point of Care Chapter
  • The advent of direct oral anticoagulants (DOACs) has catalyzed key changes in the treatment landscape for atrial fibrillation (AFib) and venous thromboembolism (VTE). DOACs are increasingly prescribed, and their use as first-line agents for VTE treatment and stroke prevention in nonvalvular AFib (NVAF) in ... more >>
  • Stroke Prevention — Venous Thromboembolism (VTE) Prophylaxis and Treatment in Patients With Cancer – @Point of Care Chapter
  • Cancer-associated venous thromboembolism (VTE) occurs more frequently than in the general population. Anticoagulant therapy for primary thromboprophylaxis, treatment of cancer-associated VTE, and secondary thromboprophylaxis can reduce the risk of initial VTE and recurrent VTE. Direct oral anticoagulants ( ... more >>
    A. Spyropoulos, MD, FACP, FCCP, FRCPC
  • Cardiology Care Considerations — ACC: Analyses Find SGLT2i Therapy Effective But Underutilized – BreakingMED
  • In a series of presentations at ACC.21, the virtual meeting of the American College of Cardiology, researchers delivered data to confirm two observations about cardiovascular outcomes in heart failure patients with or without type 2 diabetes (T2D) and/or chronic kidney disease (CDK). First, the use of SGLT2 ... more >>
    K. Rodowicz, DO
  • Heart Failure — Patient With HFrEF and Recent Hospitalization Who is Worsening on Current Therapy – @Point of Care Chapter
  • Patients with heart failure with reduced ejection fraction are at high risk of disease-related morbidity and mortality. Several classes of medications have been shown to be effective in reducing these outcomes, but even with optimized guideline-directed medical therapy (GDMT), some patients continue to have ... more >>
    J. Butler, MD, MPH, MBA
  • Cardiology Care Considerations — ACC: Investigational MRA Reduces New Onset AFib in CKD/T2D – BreakingMED
  • The spectrum of cardiovascular disease in patients with type 2 diabetes and chronic kidney disease includes a full range of conditions, including heart rhythm disorders, which in turn can trigger heart failure and stroke; however, an investigational agent may keep the heart in sync, according to findings from ... more >>
    A. Brixey, MD
  • Pulmonary Arterial Hypertension @Point of Care
  • Pulmonary arterial hypertension (PAH) is a rare disorder associated with significant morbidity and mortality. Three PAH treatment pathways or targets have been identified—the endothelin pathway, the nitric oxide pathway, and the prostacyclin pathway. In 1995 the FDA approved the first treatment specifically ... more >>
    R. Channick, MD
  • Heart Failure @Point of Care
  • Heart failure is a significant health burden and, with increasing comorbidities and the aging of the population, this burden is likely to worsen especially in certain populations. Guideline-directed medical therapies have been shown to reduce morbidity and mortality in patients with heart failure, but are ... more >>
    G. Fonarow, MD
  • Hypercholesterolemia @Point of Care
  • The Hypercholesterolemia @Point of Care platform provides comprehensive and current information organized into a progressive series of activities and patient cases covering guideline-recommended diagnostic and treatment strategies with up-to-date clinical trial data and insights from top specialists. ... more >>
    M. Miller, MD
  • Stroke Prevention in Atrial Fibrillation and VTE @Point of Care
  • Stroke Prevention in Atrial Fibrillation and VTE @Point of Care is a clinical decision-making tool that provides a streamlined, comprehensive mobile reference for clinicians to obtain information on the diagnosis, treatment and management of Atrial Fibrillation and VTE. It is made up of a progressive series ... more >>
    S. Connolly, MD, FRCPC
  • Cardiology Care Considerations — Special Considerations in Cardiology: The Era of Covid-19 – Webcast
  • Early in the Covid-19 pandemic clinicians recognized that this was not simply another flu-like condition but rather an aggressive virus that attacked multiple organ systems. In this exclusive Special Considerations video interview Robert O. Bonow, MD, MS, professor of cardiology at Northwestern University’s ... more >>
  • Cardiology Care Considerations — Special Considerations in Cardiology Post Covid-19: What We Know Now – Webcast
  • In year 2 of the Covid-19 Pandemic there is now a regular flow of findings about the nature of the virus, the efficacy of treatments and the protection offered by vaccines. But still unknown are ways to protect organ systems—including the cardiovascular system—from long term sequelae. In this exclusive ... more >>
  • Cardiology Care Considerations — A Patient With High-Burden Atrial Fibrillation and the Comorbidities of Obesity and Diabetes – Webcast
  • Obesity and diabetes are common among patients with atrial fibrillation (AFib). These comorbidities present a challenge to the management of AFib as well as to the overall health, well-being, and quality of life of the patient. Join Andrew Ha, MD, MSc, FRCPC, as he follows a 69-year-old man with a history of ... more >>
  • Cardiology Care Considerations — A Patient With Atrial Fibrillation and Chronic Renal Disease – Webcast
  • Caring for patients with atrial fibrillation who have complex medical histories requires that clinicians take into account many factors when making anticoagulation treatment decisions. Clinicians also need to address patient desires and concerns regarding the available options through the process of shared ... more >>
  • Cardiology Care Considerations — SGLT-2 Inhibitors Morning Commute: Widening Benefit – Podcast
  • Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are showing wide benefit beyond glycemic control. In this episode, our faculty will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.
    J. Januzzi, MD
  • Cardiology Care Considerations — SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection – Podcast
  • In this episode our faculty discuss how SGLT-2 inhibitors evolved from treatments for type 2 diabetes mellitus to key treatments for patients with heart failure, by looking at the pivotal trials that thrust these treatments into the heart failure treatment limelight.
    J. Januzzi, MD
  • Cardiology Care Considerations — SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action – Podcast
  • In this episode, our faculty discuss the surge in collaboration between primary care physicians, endocrinologists, and cardiologists and the groundswell of cardiometabolic clinics. They discuss the recent guidelines from the American Diabetes Association and the American College of Cardiologists that now ... more >>
    J. Januzzi, MD
  • Stroke Prevention — A Patient With a New Diagnosis of Atrial Arrhythmia Following a Recent Stent Placement – Webcast
  • Integration of patient-reported objective data, such as weight, blood pressure, and electrocardiograms, helps to provide a timely diagnosis that correlates with symptoms, as well as serves as a means of tracking arrhythmia trends over time and assessing response to therapy. Join Sanjaya Gupta, MD, FACC, FHRS, ... more >>
  • Stroke Prevention — Patient With Atrial Fibrillation at High Risk for Stroke or Thromboembolism Who Underwent Percutaneous Intervention for Acute Coronary Syndrome – Webcast
  • Patients with atrial fibrillation who undergo percutaneous intervention to treat acute coronary syndrome need highly personalized monitoring and treatment decision-making to manage the ongoing risks of stroke or thromboembolism, bleeding, and recurrent cardiac ischemic event following percutaneous ... more >>
  • Cardiology Care Considerations — Cardiology Journal Club – Podcast
  • The Covid-19 pandemic has hit patients with cardiovascular disease particularly hard. Moreover, cardiovascular disease sequelae are plaguing Covid-19 patients who did not have heart disease to begin with. Our faculty discusses several papers related to cardiology issues as well as what they are seeing in ... more >>
    M. Walsh, MD
  • Cardiology Care Considerations — Treatment of an Elderly Patient at High Risk for Stroke During the Covid-19 Pandemic – Case Study
  • The Covid-19 pandemic has affected all aspects of healthcare. This case illustrates the treatment of a patient diagnosed with atrial fibrillation in the spring of 2020, and highlights both best practice for the treatment of atrial fibrillation and considerations of the impact SARS-CoV-2 can have on patients ... more >>
    P. Dorian, MD
  • Heart Failure — Patient With Worsening HFrEF and Prediabetes – Case Study
  • Patients with heart failure with reduced ejection fraction (HFrEF) should be managed using guideline-directed medical therapy, and include use of agents that modulate all pathways known to affect HF outcomes. This includes evidence-based beta blockers and agents that inhibit the renin-angiotensin-aldosterone ... more >>
    J. Butler, MD, MPH, MBA
  • Heart Failure — Patient With Worsening HFrEF and Multiple Hospitalizations – Case Study
  • Patients with heart failure (HF) with reduced ejection fraction should be managed using guideline-directed medical therapy, which includes agents that block the renin-angiotensin system, such as angiotensin converting enzymes inhibitors, angiotensin receptor blockers, or angiotensin receptor-neprilysin ... more >>
    J. Udelson, MD
  • Heart Failure — Optimizing Treatment for a Patient With Hypertension and HFrEF – Case Study
  • Patients with heart failure with reduced ejection fraction should be managed using recent clinical trial outcomes and guideline-directed medical therapy (GDMT), which include agents that block the renin-angiotensin-aldosterone system. This case illustrates the real-life clinical scenario of a patient who ... more >>
    K. Ferdinand, MD
  • Heart Failure — Managing a Hispanic Patient With Diabetes, High Cholesterol, and Heart Failure With Reduced Ejection Fraction – Case Study
  • This case demonstrates the real-life clinical scenario of the initial presentation of a patient with heart failure and comorbidities. It demonstrates guideline- and evidence-based diagnosis and treatment of such patients, with emphasis on the need for early initiation of treatment in order to prevent or ... more >>
    Y. Selektor, MD
  • Heart Failure — Managing an Elderly Heart Failure Patient With Hypertension – Case Study
  • This case discusses the real-life clinical scenario of an elderly patient with hypertension and symptoms of heart failure (HF), and describes the common progression of hypertension to HF with advancing age. The case emphasizes evidence-based treatment, as multiple therapies have been shown to be effective for ... more >>
    M. Dunlap, MD
  • Heart Failure — Managing a Heart Failure Patient With Cardiovascular Disease – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with diabetes and hypertension, illustrating the work-up and diagnosis of her cardiovascular disease and heart failure. The case also highlights the guideline-recommended strategies for the treatment and subsequent optimization of medical ... more >>
    E. Hsich, MD
  • Heart Failure — Managing a Patient With Cardiovascular Disease and Severe Renal Impairment – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with symptomatic heart failure and a reduced ejection fraction and renal impairment, and discusses guideline-directed medical therapy for such patients. Patients with renal impairment are eligible for treatment with most of the Class I ... more >>
    E. Hsich, MD
  • Heart Failure — Managing a Hypertensive Black Patient With a Reduced Ejection Fraction – Case Study
  • This case demonstrates the real-life clinical scenario of a black patient with hypertension and heart failure with a reduced ejection fraction, highlighting the guideline-recommended strategies for initial treatment and subsequent optimization in black patients with heart failure.
    J. Udelson, MD
  • Heart Failure — Managing a Patient With a Rapid Heart Beat, Symptomatic HF, and Intolerance to Beta Blockers – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with symptomatic heart failure and a reduced ejection fraction with a rapid heart rate. Guideline-directed medical therapy includes use of beta blockers, but this patient was intolerant to all but a modest dose of these agents. The evidence ... more >>
    J. Udelson, MD

    We appreciate our customers and hold ourselves to the highest privacy standards.

    Access My Information or Delete My Information